COVID RAPID TESTS
In Stock · Limited Supply
COVID-19 AG RAPID TEST DEVICE
High-performance rapid test for patients suspected of current COVID-19 infection
Enables immediate treatment or isolation measures to minimize transmission.
Patient-friendly nasal or nasopharyngeal sample collection types.
Accessible, large-scale testing helps contain the virus spread.
Fast identification of potentially contagious individuals
Test results in 15 minutes
Deploy at large scale at point-of-care
Can be used in a wide variety of non-laboratory settings
No special/additional instruments required
Self-contained tube with “break off” swab minimizes staff exposure
The extraction tube is fully enclosed for disposal
Test Sensitivity = 91.4%
BENEFITS OF RAPID TESTS
Rapid Test & Trace Goals
Help Canadians get rapid tests to fight COVID-19
Quickly increase daily rapid testing across Canada
Develop an information hub and reference site for COVID-19 information and prevention
Rapid tests are viewed as a critical tool to help stop the spread of COVID-19 in Canada. The primary benefits of rapid tests include:
the ability for non-professionals to perform the testing
lower cost compared to PCR tests
faster turnaround times
These beneficial characteristics of rapid testing mean the rapid tests can become more widely used as a screening tool for COVID-19, which is particularly important in Canada, where COVID-19 vaccines need to be imported and have experienced distribution delays. It also helps people return to work or school faster after the appearance of symptoms, allowing Canadians to return to normal faster.
BULK TESTING KITS FOR BUSINESSES
Small and medium-sized organization test kit dispensing available
As part of the federally funded rapid antigen tests initiative, Columbia Street Pharmacy is involved in dispensing and training businesses and non-profits with POC test kits.
This will enable small-to-medium size enterprises (SME) access to Rapid Test at an economical price to distribute and test their employees to reduce the spread of Covid. SMEs are businesses with 10 to 199 employees and screening & reporting is required. Please see the pharmacy for more information.
Small and medium organizations (10 to 199 employees) can access rapid COVID-19 tests from Columbia Street Pharmacy for workplace screening initiatives.
How to register and get kits
Register your organization online through the Health Canada registration.
Review and sign the BC Letter of Agreement and email it to rapidpocregistrybc@phsa.ca
You will receive a confirmation email. Please keep the email for the pharmacist to review.
Review Abbott Panbio™ COVID-19 Antigen Rapid Test (nasal) guidelines and requirements and competency assessment/checklist in Appendix I
Print a copy of the competency assessment
Bring a COPY of your confirmation email to Columbia Street Pharmacy and a pharmacist will provide training and help you complete the assessment.
Keep the competency assessment as a record to show that your organization has completed the required training and demonstrated the necessary competency to operationalize a workplace screening program.
Test kits contain 25 tests. Kits are provided for free by the Government of Canada; Columbia Street Pharmacy charges $14 per kit for handling and training fees.
INTENDED USE
Types of tests
There are 2 kinds of tests: diagnostic and screening tests.
Diagnostic tests, such as polymerase chain reaction (PCR) tests, can confirm if someone has COVID-19, with results available in 24 to 48 hours.
Screening, through the use of rapid detection tests (RADTs, or rapid tests), can potentially identify positive cases earlier (within 15 minutes) to help reduce the spread of the virus and prevent outbreaks. When used regularly, rapid tests may help identify individuals who may be infectious early on. Individuals can be pre-symptomatic or asymptomatic but still carry the virus and may transmit it to others.
Those receiving a positive rapid test result should seek a PCR test as soon as possible for a confirmatory diagnosis. This also allows local public health authorities to identify the nature of the virus and track variants of concern. Please follow all isolation and quarantine advice given by public health officials while you wait for test results.
A COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasal swab specimens from individuals who meet COVID-19 clinical and / or epidemiological criteria. Panbio™ COVID-19 Ag Rapid Test Device is for professional use only and is intended to be used as an aid in the diagnosis of SARS-CoV-2 infection. The test provides preliminary test results. Negative results don’t preclude SARSCoV-2 infection and they cannot be used as the sole basis for treatment or other management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The test is not
intended to be used as a donor screening test for SARS-CoV-2.